Droplet-based microfluidics in drug discovery, transcriptomics and high-throughput molecular genetics

Area of Science:

• Biotechnology
• Genomics
• Drug Discovery

Background:

• Droplet-based microfluidics enables high-throughput assays with minimal sample and reagent volumes.
• This technology facilitates large-scale genotypic and phenotypic screening at the single-cell level.
• It is particularly valuable for analyzing precious samples like primary cells and patient biopsies.

Purpose of the Study:

• To critically review recent advancements in droplet-based microfluidics for various applications.
• To identify current limitations and potential solutions in the field.
• To provide an outlook on future applications of single-cell analysis.

Main Methods:

• Review of the latest developments in antibody screening.
• Analysis of droplet-based microfluidics in drug discovery.
• Examination of highly multiplexed genomic applications, including targeted genetic workflows, single-cell RNA sequencing (scRNAseq), and single-cell ChIP sequencing (scChIPseq).

Main Results:

• The review highlights significant progress in applying droplet microfluidics to antibody screening and drug discovery.
• Key developments in single-cell genomic applications like scRNAseq and scChIPseq are detailed.
• Current technological limitations are identified, alongside strategies for overcoming them.

Conclusions:

• Droplet-based microfluidics is a transformative technology for high-throughput, single-cell analysis.
• Continued innovation is expected to expand its utility in biological research and medicine.
• Future applications hold promise for personalized medicine and advanced diagnostics.